Robert Cole, MD
Advanced Heart Failure and Transplant Cardiology · Atlanta, GANPI 1871770735
Payments from drug & device makers
Across 584 payments — averaging $409.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$75K
- Boehringer Ingelheim$62K
- Cvrx, Inc.$54K
- Impulse Dynamics (USA) Inc.$16K
- Lilly USA, LLC$14K
- Endotronix, Inc.$10K
- plus $8K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 229 | $75,176 |
| Boehringer Ingelheim | 71 | $62,406 |
| Cvrx, Inc. | 117 | $53,733 |
| Impulse Dynamics (USA) Inc. | 5 | $16,171 |
| Lilly USA, LLC | 11 | $13,800 |
| Endotronix, Inc. | 1 | $10,000 |
| Boston Scientific | 4 | $3,769 |
| Novartis | 63 | $1,069 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $563 |
| AstraZeneca(2 entities) | 10 | $274 |
| Paragonix Technologies, Inc. | 2 | $246 |
| Pfizer | 10 | $221 |
| Eurofins Viracor, LLC | 2 | $164 |
| Abiomed | 1 | $153 |
| Merck | 7 | $140 |
| Johnson & Johnson | 2 | $136 |
| Sensible Medical Innovations Inc | 1 | $132 |
| E.r. Squibb & Sons, L.L.C. | 6 | $115 |
| Picard Medical Inc. | 1 | $109 |
| Alnylam Pharmaceuticals Inc. | 3 | $102 |
| Actelion Pharmaceuticals US, Inc. | 3 | $56 |
| Novo Nordisk | 3 | $52 |
| Briohealth Solutions, Inc. | 1 | $49 |
| Bayer | 2 | $36 |
| Lexicon Pharmaceuticals, Inc. | 2 | $34 |
| KCI USA, Inc. | 1 | $27 |
| Sanofi | 1 | $22 |
| Atricure, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Argon Medical Devices, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
How this compares
$238,902 in reported general payments places this provider in the 75th percentile of 40 advanced heart failure and transplant cardiology providers in Georgia.
See all advanced heart failure and transplant cardiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Atlanta
- Chad MaoAtlanta$1.3M
- Andrew SmithAtlanta$413K
- Rahul LounganiAtlanta$221K
- Kunal BhattAtlanta$220K
- Arun KrishnamoorthyAtlanta$146K
- Divya GuptaAtlanta$104K
- Brenda HottAtlanta$25K
- Michael BurkeAtlanta$24K
- Benjamin DemossAtlanta$17K
- Mehrdad ToosiAtlanta$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.